Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Antengene Corporation Limited ( (HK:6996) ) has provided an announcement.
Antengene Corporation Limited has announced that its board of directors will meet on March 21, 2025, to consider and approve the company’s annual results for the year ending December 31, 2024. This meeting is significant as it will impact the company’s financial reporting and provide insights into its performance, potentially influencing investor and stakeholder perspectives.
More about Antengene Corporation Limited
Antengene Corporation Limited is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative oncology therapies.
YTD Price Performance: 437.50%
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €233.8M
Find detailed analytics on 6996 stock on TipRanks’ Stock Analysis page.